The Valley Desk

NCT07215910 · Interventional trial

Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer

Overall registry status Recruiting

Phase 3

Conditions Astrocytoma, IDH-Mutant, Grade 3

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov